These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19393851)

  • 1. An open-label, single-dose, parallel-group, dose-increasing study comparing the pharmacokinetics and tolerability of pilsicainide hydrochloride in healthy Korean and Japanese male subjects.
    Kim BH; Kim JR; Lim KS; Kim JW; Kim KP; Hong JH; Jang IJ; Shin SG; Yu KS; Tanaka T
    Clin Ther; 2009 Mar; 31(3):609-18. PubMed ID: 19393851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of pilsicainide hydrochloride for injection in healthy Chinese volunteers: a randomized, parallel-group, open-label, single-dose study.
    Qiu Q; Liu W; Li J; Wei Y; Yang K; Suo W; Wu W; Du H; Zhang Y; Zhao G; Zhou Z; Zheng Y; Lin Y
    Clin Ther; 2014 Feb; 36(2):255-63. PubMed ID: 24480637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic comparison of controlled-release and immediate-release oral formulations of simvastatin in healthy Korean subjects: a randomized, open-label, parallel-group, single- and multiple-dose study.
    Jang SB; Lee YJ; Lim LA; Park KM; Kwon BJ; Woo JS; Kim YI; Park MS; Kim KH; Park K
    Clin Ther; 2010 Jan; 32(1):206-16. PubMed ID: 20171425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose, randomized, open-label, 2-way crossover study of the pharmacokinetics of amitriptyline hydrochloride 10- and 25-mg tablet in healthy male Korean volunteers.
    Nam Y; Lim CH; Lee HS; Chung SJ; Chung YH; Shin YK; Kim MG; Sohn UD; Kim HC; Jeong JH
    Clin Ther; 2015 Feb; 37(2):302-10. PubMed ID: 25308868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers.
    Kim TE; Kim BH; Kim J; Kim KP; Yi S; Shin HS; Lee YO; Lee KH; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Oct; 31(10):2249-57. PubMed ID: 19922896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and pharmacokinetics of ranolazine following single and multiple sustained-release doses in Chinese healthy adult volunteers: a randomized, open-label, Latin square design, phase I study.
    Tan QY; Li HD; Zhu RH; Zhang QZ; Zhang J; Peng WX
    Am J Cardiovasc Drugs; 2013 Feb; 13(1):17-25. PubMed ID: 23355361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
    Lim KS; Kim JR; Choi YJ; Shin KH; Kim KP; Hong JH; Cho JY; Shin HS; Yu KS; Shin SG; Kwon OH; Hwang DM; Kim JA; Jang IJ
    Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic properties of the calcimimetic agent cinacalcet (KRN1493) in healthy male Korean subjects: a randomized, open-label, single ascending-dose, parallel-group study.
    Lee S; Gu N; Kim BH; Lim KS; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2012 May; 34(5):1160-9. PubMed ID: 22503212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: an open-label, single-dose, randomized, two-way crossover study in healthy Chinese male volunteers.
    Liu Y; Jia J; Liu G; Li S; Lu C; Liu Y; Yu C
    Clin Ther; 2009 Apr; 31(4):777-83. PubMed ID: 19446150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic comparison of orally disintegrating and conventional donepezil formulations in healthy Korean male subjects: a single-dose, randomized, open-label, 2-sequence, 2-period crossover study.
    Kim KA; Lim JL; Kim C; Park JY
    Clin Ther; 2011 Jul; 33(7):965-72. PubMed ID: 21723605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and bioequivalence evaluation of two different atorvastatin calcium 10-mg tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy fasted Chinese adult males.
    Liu YM; Pu HH; Liu GY; Jia JY; Weng LP; Xu RJ; Li GX; Wang W; Zhang MQ; Lu C; Yu C
    Clin Ther; 2010 Jul; 32(7):1396-407. PubMed ID: 20678686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic properties of a single intravenous dose of ibutilide fumarate: a phase I, randomized, open-label, increasing-dose study in healthy Chinese men.
    Li Y; Tian L; Huang Y; Hua L
    Clin Ther; 2007 Sep; 29(9):1957-66. PubMed ID: 18035195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetic evaluation of two formulations of bicalutamide 50-mg tablets: an open-label, randomized-sequence, single-dose, two-period crossover study in healthy Korean male volunteers.
    Lee S; Chung YJ; Kim BH; Shim JH; Yoon SH; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Dec; 31(12):3000-8. PubMed ID: 20110037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic (hemodynamic) and pharmacokinetic comparisons of S-amlodipine gentisate and racemate amlodipine besylate in healthy Korean male volunteers: two double-blind, randomized, two-period, two-treatment, two-sequence, double-dummy, single-dose crossover studies.
    Kim BH; Kim JR; Kim MG; Kim KP; Lee BY; Jang IJ; Shin SG; Yu KS
    Clin Ther; 2010 Jan; 32(1):193-205. PubMed ID: 20171424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative bioavailability of levodropropizine 60 mg capsule and syrup formulations in healthy male Korean volunteers: a singledose, randomized-sequence, open-label, two-way crossover study.
    Jang JW; Seo JH; Jo MH; Lee YJ; Cho YW; Yim SV; Lee KT
    Int J Clin Pharmacol Ther; 2013 Feb; 51(2):152-60. PubMed ID: 23351597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic, tolerability, and bioequivalence comparison of three different intravenous formulations of recombinant human erythropoietin in healthy Korean adult male volunteers: an open-label, randomized-sequence, three-treatment, three-way crossover study.
    Cho SH; Lim HS; Ghim JL; Choe S; Kim UJ; Jung JA; Bae KS
    Clin Ther; 2009 May; 31(5):1046-53. PubMed ID: 19539105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative bioavailability and tolerability of a single 20-mg dose of two fluoxetine hydrochloride dispersible tablet formulations in fasting, healthy Chinese male volunteers: an open-label, randomized-sequence, two-period crossover study.
    Shi S; Liu Y; Wu J; Li Z; Zhao Y; Zhong D; Zeng F
    Clin Ther; 2010 Oct; 32(11):1977-86. PubMed ID: 21095492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the bioavailability and tolerability of fixed-dose combination glimepiride/metformin 2/500-mg tablets versus separate tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy Korean volunteers.
    Gu N; Kim BH; Rhim H; Chung JY; Kim JR; Shin HS; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2010 Jul; 32(7):1408-18. PubMed ID: 20678687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic properties and bioequivalence of two compound formulations of 1500 mg ampicillin (1167 mg)/probenecid (333 mg): a randomized-sequence, single-dose, open-label, two-period crossover study in healthy Chinese male volunteers.
    Wu H; Liu M; Wang S; Feng W; Yao W; Zhao H; Wei M
    Clin Ther; 2010 Mar; 32(3):597-606. PubMed ID: 20399996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.